As a generally held principle, mere investment or ownership interest in a company does not expose the investor to liability for acts undertaken by the company. However, that principle is being called into question in the context of private equity firms investing in healthcare companies. In two recent cases, healthcare companies along with their sole or majority private equity firm owners settled False Claims Act (“FCA”) cases. These cases illustrate the risk that private equity investors in the healthcare space may face under the FCA, particularly to the extent that they actively manage their portfolio companies.
Trending
- GLP-1s linked to better IBD outcomes, hinting at role as ‘valuable adjunctive therapies’ (Healio)
- The cyber siege of private practices: Are you at risk? (Medical Economics)
- Is The Galleri Cancer Test Worth It? A Doctor Explains (Forbes)
- With a little help from my friends: What gastrointestinal pathologists need to know from gastroenterologists (GI & Hepatology News)
- The GI innovations transforming outcomes (Becker’s GI & Endoscopy)
- The Smart Toilet: Turning Waste Into Health Insights – Dr. Sonia Grego, Ph.D. (Progress, Potential, and Possibilities | YouTube)
- Peripheral gaze guidance improves adenoma detection rate (GI & Hepatology News)
- Artificial Intelligence for Gastroenterology Practice: A Modified Delphi Consensus (American Journal of Gastroenterology)
